Eton Pharmaceuticals (ETON) Total Debt (2020 - 2025)

Eton Pharmaceuticals has disclosed Total Debt across 6 years of filings, most recently posting $30.6 million for Q4 2025.

• Total Debt for Q4 2025 came in at $30.6 million, up 2.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.6 million (up 2.51% YoY), and the FY2025 annual result was $30.6 million, up 2.51% from the prior year.
• Total Debt came in at $30.6 million for Q4 2025 at Eton Pharmaceuticals, up from $30.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $30.6 million in Q4 2025 to a low of $364000.0 in Q2 2022.
• The 5-year median for Total Debt is $1.5 million (2023), against an average of $8.3 million.
• Across the five-year window, Total Debt tumbled 51.4% in 2022 and jumped 636.17% in 2025, its largest moves.
• Eton Pharmaceuticals' Total Debt stood at $1.4 million in 2021, then slipped by 27.15% to $1.0 million in 2022, then surged by 420.81% to $5.4 million in 2023, then surged by 454.11% to $29.8 million in 2024, then advanced by 2.51% to $30.6 million in 2025.
• The last three Total Debt figures came in at $30.6 million (Q4 2025), $30.4 million (Q3 2025), and $30.2 million (Q2 2025), per Business Quant data.